Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (21)
Leukemia (5)
Mucosal Immunology (1)
Nature Communications (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (24)
Correspondence (4)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Cancer
Developmental biology
Diseases
Gastroenterology
Health care
Immunology
Medical research
Physics
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–28 of 28 results

Advanced filters: Author: K-S Eom Clear advanced filters

Charge-ordering cascade with spin–orbit Mott dimer states in metallic iridium ditelluride

The influence of spin–orbit coupling on itinerant electrons underlies the formation of spin–orbit Mott states. Here, the authors demonstrate a temperature-hysteretic cascade between charge-ordered phases stabilized by localized 5dspin–orbit Mott dimer states in metallic iridium ditelluride.

K.-T. Ko
H.-H. Lee
J.-H. Park
Research10 Jun 2015
Nature Communications

Volume: 6, P: 1-7
Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia

H-J Kim
W-S Min
C-C Kim
Research08 Oct 2007
Bone Marrow Transplantation

Volume: 40, P: 1069-1074
Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse

C-K Min
S Y Kim
C C Kim
Research23 Jan 2006
Bone Marrow Transplantation

Volume: 37, P: 493-498
Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure

S-H Shin
S-A Yahng
Y-J Kim
Research05 Nov 2012
Bone Marrow Transplantation

Volume: 48, P: 678-683
Autologous stem cell transplantation using modified TAM or combination of triple-alkylating agents conditioning regimens as one of the post-remission treatments in patients with adult acute myeloid leukemia in first complete remission

H-J Kim
W-S Min
C-C Kim
Research31 May 2004
Bone Marrow Transplantation

Volume: 34, P: 215-220
Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning

S H Shin
Y W Jeon
J W Lee
Research27 Jun 2016
Bone Marrow Transplantation

Volume: 51, P: 1456-1463
HLA-matched sibling transplantation with BM and CD34⁺-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD

B S Cho
K S Eom
J W Lee
Research11 Jan 2010
Bone Marrow Transplantation

Volume: 45, P: 1497-1501
Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia

S-E Lee
S-A Yahng
J W Lee
Research23 May 2016
Bone Marrow Transplantation

Volume: 51, P: 1323-1329
Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patients

C-K Min
K-S Eom
CC Kim
Research02 Jul 2001
Bone Marrow Transplantation

Volume: 27, P: 999-1005
Distribution of the minor histocompatibility antigens in Korean population and disparities in unrelated hematopoietic SCT

M-J Park
H-B Choi
T-G Kim
Research13 Aug 2007
Bone Marrow Transplantation

Volume: 40, P: 723-728
Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?

J-H Yoon
W-S Min
C-W Park
Research29 Jul 2013
Bone Marrow Transplantation

Volume: 48, P: 1562-1568
PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL

S-H Shin
J-H Yoon
S Lee
Research24 Mar 2014
Bone Marrow Transplantation

Volume: 49, P: 773-779
Risk and prognostic factors for acute GVHD based on NIH consensus criteria

S-E Lee
B-S Cho
C-W Park
Research24 Sept 2012
Bone Marrow Transplantation

Volume: 48, P: 587-592
Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML

H-J Kim
W-S Min
C-C Kim
Research09 Mar 2009
Bone Marrow Transplantation

Volume: 44, P: 345-351
Feasibility of NIH consensus criteria for chronic graft-versus-host disease

B-S Cho
C-K Min
C-C Kim
Research02 Oct 2008
Leukemia

Volume: 23, P: 78-84
MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease

J-Y Lim
Y-K Lee
C-K Min
Research01 May 2016
Mucosal Immunology

Volume: 9, P: 730-743
The genetic characterization of acute promyelocytic leukemia with cryptic t(15;17) including a new recurrent additional cytogenetic abnormality i(17)(q10)

M Kim
J Lim
W-S Min
Correspondence18 Oct 2007
Leukemia

Volume: 22, P: 881-883
Potential role of adoptively transferred allogeneic WT1-specific CD4⁺ and CD8⁺ T lymphocytes for the sustained remission of refractory AML

Y-J Kim
S-G Cho
T-G Kim
Correspondence17 Aug 2009
Bone Marrow Transplantation

Volume: 45, P: 597-599
Azacytidine treatment after discontinuation of immunosuppressants in patients with myelodysplastic syndrome and relapse after allo-SCT at a single center

S-Y Kim
S-G Cho
W-S Min
Correspondence21 Dec 2009
Bone Marrow Transplantation

Volume: 45, P: 1375-1376
Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation

M Kim
S-A Yahng
Y-J Kim
Correspondence11 May 2015
Bone Marrow Transplantation

Volume: 50, P: 1132-1134
Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation

J-H Yoon
H-J Kim
C-W Park
Research11 Aug 2014
Bone Marrow Transplantation

Volume: 49, P: 1466-1474
Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia

S Lee
N-G Chung
C-C Kim
Research30 Sept 2010
Leukemia

Volume: 24, P: 2110-2119
Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia

S Lee
D-W Kim
C-W Park
Research18 Jun 2012
Leukemia

Volume: 26, P: 2367-2374
Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

B-S Cho
C-K Min
C-C Kim
Research21 Jan 2008
Bone Marrow Transplantation

Volume: 41, P: 813-820
Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL

M Kim
J Park
S Lee
Research15 Dec 2014
Bone Marrow Transplantation

Volume: 50, P: 354-362
Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome

S-A Yahng
Y-W Jeon
Y-J Kim
Research28 Nov 2016
Bone Marrow Transplantation

Volume: 52, P: 522-531
Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study

B-S Cho
S Lee
C-C Kim
Research14 May 2009
Leukemia

Volume: 23, P: 1763-1770
Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation

C-K Min
S Y Kim
C S Cho
Research05 Jun 2006
Bone Marrow Transplantation

Volume: 38, P: 149-156

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Charge-ordering cascade with spin–orbit Mott dimer states in metallic iridium ditelluride

Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia

Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse

Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure

Autologous stem cell transplantation using modified TAM or combination of triple-alkylating agents conditioning regimens as one of the post-remission treatments in patients with adult acute myeloid leukemia in first complete remission

Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning

HLA-matched sibling transplantation with BM and CD34⁺-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD

Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia

Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patients

Distribution of the minor histocompatibility antigens in Korean population and disparities in unrelated hematopoietic SCT

Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?

PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL

Risk and prognostic factors for acute GVHD based on NIH consensus criteria

Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML

Feasibility of NIH consensus criteria for chronic graft-versus-host disease

MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease

The genetic characterization of acute promyelocytic leukemia with cryptic t(15;17) including a new recurrent additional cytogenetic abnormality i(17)(q10)

Potential role of adoptively transferred allogeneic WT1-specific CD4⁺ and CD8⁺ T lymphocytes for the sustained remission of refractory AML

Azacytidine treatment after discontinuation of immunosuppressants in patients with myelodysplastic syndrome and relapse after allo-SCT at a single center

Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation

Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation

Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia

Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia

Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL

Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome

Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study

Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation

Search

Quick links